Drug · DIN 02545004
EYLEA HD
8 MG/70 MCL SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 3, 2024; first marketed September 3, 2024.
- Drug Identification Number (DIN)
- 02545004
- Company (DIN owner)
- Bayer Inc.Elkhart, Indiana, United States
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Aflibercept S01LA05
- Class
- Human
- Record last updated
- September 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AFLIBERCEPT | 8 MG | 0.07 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 2, 2024: NOC 32638Supplement to a New Drug Submission (SNDS) · Addition of a new strength and addition of alternate dosing regimen
Other DINs named EYLEA HD
- DIN 02554798 · Marketed